Edition:
United States

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

10.82USD
15 Dec 2017
Change (% chg)

$-0.61 (-5.34%)
Prev Close
$11.43
Open
$11.22
Day's High
$12.17
Day's Low
$10.53
Volume
392,616
Avg. Vol
--
52-wk High
$15.39
52-wk Low
$9.94

Chart for

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)

Overall

Beta: --
Market Cap(Mil.): $144.96
Shares Outstanding(Mil.): 13.40
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

Earnings vs. Estimates